APA (7th ed.) Citation

B, W., ETY, T., CSL, C., CLK, L., & EYF, W. (2026). Optimising lipid monitoring interval for primary prevention of cardiovascular disease in patients with type-2 diabetes: A target trial emulation study. Diabetes research and clinical practice, 234, 113156. https://doi.org/10.1016/j.diabres.2026.113156

Chicago Style (17th ed.) Citation

B, Wang, Tse ETY, Chui CSL, Lam CLK, and Wan EYF. "Optimising Lipid Monitoring Interval for Primary Prevention of Cardiovascular Disease in Patients with Type-2 Diabetes: A Target Trial Emulation Study." Diabetes Research and Clinical Practice 234 (2026): 113156. https://doi.org/10.1016/j.diabres.2026.113156.

MLA (9th ed.) Citation

B, Wang, et al. "Optimising Lipid Monitoring Interval for Primary Prevention of Cardiovascular Disease in Patients with Type-2 Diabetes: A Target Trial Emulation Study." Diabetes Research and Clinical Practice, vol. 234, 2026, p. 113156, https://doi.org/10.1016/j.diabres.2026.113156.